Article
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
The American journal of gastroenterology - 1 Sept 2002
Zampino Rosa, Marrone Aldo, Karayiannis Peter, Cirillo Grazia, del Giudice Emanuele Miraglia, Rania Giovanni, Utili Riccardo, Ruggiero Giuseppe
Abstract excerpt
OBJECTIVES: In this study, we aimed to evaluate the persistence of hepatitis B virus (HBV) DNA and the role of HBV core promoter and precore region mutations in 28 young cancer survivor patients with HBV or HBV and hepatitis C virus (HCV) infections, and persistently normal ALT levels, after spontaneous or interferon (IFN)-induced anti-hepatitis B e (HBe) seroconversion. METHODS: Sera from 15 patients with HBV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
